Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.44B |
| Enterprise value | 2.08B |
| Trailing P/E | 25.80 |
| Forward P/E | 21.01 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.71 |
| Price/book (mrq) | 4.58 |
| Enterprise value/revenue | 5.90 |
| Enterprise value/EBITDA | 17.19 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.68 |
| 52-week change 3 | -11.85% |
| S&P500 52-week change 3 | 22.93% |
| 52-week high 3 | 31.18 |
| 52-week low 3 | 17.57 |
| 50-day moving average 3 | 20.57 |
| 200-day moving average 3 | 21.84 |
Share statistics
| Avg vol (3-month) 3 | 695.21k |
| Avg vol (10-day) 3 | 1.22M |
| Shares outstanding 5 | 115.93M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 96.33M |
| % held by insiders 1 | 9.97% |
| % held by institutions 1 | 71.30% |
| Shares short (14 Nov 2021) 4 | 8.96M |
| Short ratio (14 Nov 2021) 4 | 12.62 |
| Short % of float (14 Nov 2021) 4 | 11.71% |
| Short % of shares outstanding (14 Nov 2021) 4 | 7.76% |
| Shares short (prior month 14 Oct 2021) 4 | 8.4M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 29 Sept 2021 |
Profitability
| Profit margin | 30.17% |
| Operating margin (ttm) | 33.53% |
Management effectiveness
| Return on assets (ttm) | 13.21% |
| Return on equity (ttm) | 20.67% |
Income statement
| Revenue (ttm) | 352.89M |
| Revenue per share (ttm) | 3.03 |
| Quarterly revenue growth (yoy) | 11.40% |
| Gross profit (ttm) | 348.29M |
| EBITDA | 119.18M |
| Net income avi to common (ttm) | 106.45M |
| Diluted EPS (ttm) | 0.83 |
| Quarterly earnings growth (yoy) | 40.90% |
Balance sheet
| Total cash (mrq) | 361.33M |
| Total cash per share (mrq) | 3.13 |
| Total debt (mrq) | 1.05M |
| Total debt/equity (mrq) | 0.19 |
| Current ratio (mrq) | 8.98 |
| Book value per share (mrq) | 4.68 |
Cash flow statement
| Operating cash flow (ttm) | 153.54M |
| Levered free cash flow (ttm) | 113.33M |
© 2021 Yahoo. All rights reserved.
